title: Pneumocystis carinii pneumonia following a second infusion of infliximab.
authors.forename: T L
authors.initials: TL
authors.lastname: Tai
authors.forename: K P
authors.initials: KP
authors.lastname: O'Rourke
authors.forename: M
authors.initials: M
authors.lastname: McWeeney
authors.forename: C M
authors.initials: CM
authors.lastname: Burke
authors.forename: K
authors.initials: K
authors.lastname: Sheehan
authors.forename: M
authors.initials: M
authors.lastname: Barry
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D006801:Humans; D000069285:Infliximab; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D009894:Opportunistic Infections / Q000139:chemically induced / Q000000981:diagnostic imaging*; D011020:Pneumonia, Pneumocystis / Q000139:chemically induced / Q000000981:diagnostic imaging*; D013902:Radiography, Thoracic; D017211:Treatment Failure
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab; D008727:Methotrexate